Financials

  • Market Capitalization 1.2 B
  • Employee 214
  • Founded 2000
  • CEO N/A
  • Website www.eyepoint.bio
  • Headquarter Delaware, United States
  • FIGI BBG000F90JX5
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-5.76
Price to sales ratio
0.04

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2319
IMTX
Immatics N.V. - Ordinary Shares
9.23 USD-4.65%-8.61%-3.55%-10.82%1.24 B USD
2320
CRVS
Corvus Pharmaceuticals, Inc. - Common Stock
14.71 USD-6.13%-3.92%+22.48%+236.61%1.24 B USD
2352
CAPR
Capricor Therapeutics, Inc. - Common Stock
20.61 USD-4.18%-8.56%-20.85%+179.65%1.19 B USD
2359
SVRA
Savara, Inc. - Common Stock
5.74 USD-4.81%-7.42%+6.89%+125.98%1.18 B USD

Frequently asked questions about EyePoint, Inc. - Common Stock

What is the EyePoint, Inc. - Common Stock stock price today?

The current price of EyePoint, Inc. - Common Stock (EYPT) is 14.28. Over the past 24 hours, the stock has changed by -2.99%. Follow the EYPT chart for real-time price dynamics.

What is the stock ticker of EyePoint, Inc. - Common Stock?

EyePoint, Inc. - Common Stock trades under the ticker EYPT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is EyePoint, Inc. - Common Stock stock going up?

EYPT has changed by -2.53% over the last week, +8.68% over the last month, and +19.00% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was EyePoint, Inc. - Common Stock net income for the last quarter?

EyePoint, Inc. - Common Stock reported net income of -84.83 M for the last quarter. The previous quarter showed -67.61 M, which means net income changed by -25.47%.

How many employees does EyePoint, Inc. - Common Stock have?

As of the latest available data, EyePoint, Inc. - Common Stock has 214 employees. Workforce size can provide additional context about the company's scale and operations.

What is EyePoint, Inc. - Common Stock EBITDA?

EyePoint, Inc. - Common Stock EBITDA is -86.59 M, and its EBITDA margin is -12.44 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy EyePoint, Inc. - Common Stock stock?

You can buy EyePoint, Inc. - Common Stock (EYPT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in EyePoint, Inc. - Common Stock stock?

Investing in EyePoint, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EYPT chart and related analysis on metatrader.com as part of your research.

EyePoint, Inc. - Common Stock

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc.

News